Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Anthony Selwyn Stein, MD, Jeffrey Y. C. Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, Biostatition, Pablo Miguel Parker, MD, Ricardo Spielberger, MD, Len Farol, MD, Guido Marcucci, MD, Eric Radany, MD, Tim Schultheiss, MD, An Liu, MD, Ibrahim Aldoss, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 735.

https://doi.org/10.1182/blood.V126.23.735.735

Published: 2015

Journal Articles

NK Cell Recovery and Costimulatory Molecule Profiles after Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM) Patients

Myo Htut, MD, Ghislaine Gallez-Hawkins, Joycelynne Palmer, PhD, Laetitia Jeannet, Leanne Goldstein, Andy Dagis, Ricardo Spielberger, MD, Pablo Miguel Parker, Len Farol, MD, Firoozeh Sahebi, MD, Chatchada Karanes, MD, Stephen J. Forman, Amrita Krishnan, MD, John A. Zaia, MD

Blood (2014) 124 (21): 2039.

https://doi.org/10.1182/blood.V124.21.2039.2039

Published: 2014

Journal Articles

Aprepitant (Emend®) Significantly Increases Sirolimus Levels In Patients Undergoing Allogeneic Hematopoietic Stem Cell transplantation.

Sepideh Shayani, Pharm.D., Joycelynne Palmer, PhD, Tracey Stiller, Chan Holly, Pharm. D., Svetlana Keuylian, Pharm.D., Pablo Miguel Parker, M.D., Stephen Forman, MD, Ryotaro Nakamura, MD

Blood (2010) 116 (21): 1311.

https://doi.org/10.1182/blood.V116.21.1311.1311

Published: 2010

Journal Articles

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

George Somlo, M.D., F.A.C.P., Ricardo Spielberger, MD, Paul Frankel, Chatchada Karanes, MD, Amrita Krishnan, MD, FACP, Pablo Miguel Parker, MD, Leslie Popplewell, Firoozeh Sahebi, Tim Schultheiss, Neil Martin Kogut, MD, An Liu, David S. Snyder, MD, Stephen J. Forman, Jeffrey Y. Wong

Blood (2008) 112 (11): 3326.

https://doi.org/10.1182/blood.V112.11.3326.3326

Published: 2008

Journal Articles

Thrombotic Microangiopathy with Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant from a Matched Unrelated Donor

Tam Khuu, PharmD, Sepideh Shayani, PharmD, Joycelynne Palmer, PhD, Roberto Rodriguez, MD, Pablo Miguel Parker, David S. Snyder, MD, Vinod Pullarkat, Joseph Rosenthal, Auayporn P. Nademanee, David Senitzer, PhD, Ryotaro Nakamura, MD, Stephen J. Forman

Blood (2008) 112 (11): 797.

https://doi.org/10.1182/blood.V112.11.797.797

Published: 2008

Journal Articles

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Sahebi Firoozeh, MD, Jeffery R. Schriber, M.D., Ricardo Spielberger, M.D., Ji-Lian Cai, M.D., Neil Martin Kogut, M.D., Peter M. Falk, M.D., Pablo Miguel Parker, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Chatchada Karanes, M.D., Dajun Qian, PhD., Stephen J. Forman, M.D., George Somlo, M.D.

Blood (2007) 110 (11): 3030.

https://doi.org/10.1182/blood.V110.11.3030.3030

Published: 2007

Journal Articles

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Kikuchi Takahide, MD, Pablo Miguel Parker, MD, Michael Wu, MD, Paul A. Carpenter, MD, Barbara Stehr, ARNP, Perry Rosenthal, MD, Paul J. Martin, MD, Stephen J. Forman, MD, Mary E.D. Flowers, MD

Blood (2006) 108 (11): 2913.

https://doi.org/10.1182/blood.V108.11.2913.2913

Published: 2006

Journal Articles

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

Bashir Ahmad, MD, Barbara Stehr, NP, Laura Johnston, MD, Eileen Patricia Smith, MD, Auayporn P. Nademanee, MD, Pablo Miguel Parker, MD, Robert Negrin, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 2894.

https://doi.org/10.1182/blood.V108.11.2894.2894

Published: 2006

Journal Articles

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

George Somlo, MD, Dajun Qian, PhD, Firoozeh Sahebi, MD, Neil Martin Kogut, MD, Roberto Rodriguez, MD, Pablo Miguel Parker, MD, Leslie Popplewell, MD, Amrita Krishnan, MD, Joycelynne Palmer, PhD, Anthony Selwyn Stein, MD, Ricardo Spielberger, MD, Jeffrey Schriber, MD, Joseph Alvarnas, MD, Warren Chow, MD, Auayporn Nademanee, MD, Jasmine M. Zain, MD, Margaret R. O’Donnell, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 3089.

https://doi.org/10.1182/blood.V108.11.3089.3089

Published: 2006

Journal Articles

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Ryotaro Nakamura, MD, Roberto Rodriguez, MD, Auayporn Nademanee, MD, Joycelynne Palmer, PhD, David Senitzer, PhD, David Snyder, MD, Jasmine Zain, MD, Vinod Pullarkat, MD, Stephen J. Forman, MD, Pablo Miguel Parker, MD

Blood (2006) 108 (11): 2866.

https://doi.org/10.1182/blood.V108.11.2866.2866

Published: 2006

Journal Articles

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Roberto Rodriguez, MD, Joycelynne Palmer, PhD, Ryotaro Nakamura, MD, Pablo Miguel Parker, MD, Auayporn P. Nademanee, MD, David S. Snyder, MD, Vinod Pullarkat, MD, Jasmine M. Zain, MD, Ricardo Spielberger, MD, David Senitzer, PhD, Stephen J. Forman, MD

Blood (2006) 108 (11): 2867.

https://doi.org/10.1182/blood.V108.11.2867.2867

Published: 2006

Journal Articles

Non-Ablative or Reduced Intensity Conditioning Regimens with Volunteer Unrelated Donor Progenitor Cell Transplantation.

Sergio Giralt, Brent Logan, Mei-Jei Zhang, Olivia McGaha, Karen Ballen, Christos Emmanouilides, Rajneesh Nath, Pablo Miguel Parker, David Porter, Brenda Sandmaier, Edmund Waller, Juliet Barker, Steven Pavletic, Daniel Weisdorf

Blood (2004) 104 (11): 2751.

https://doi.org/10.1182/blood.V104.11.2751.2751

Published: 2004

NARROW

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

NK Cell Recovery and Costimulatory Molecule Profiles after Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM) Patients

Aprepitant (Emend®) Significantly Increases Sirolimus Levels In Patients Undergoing Allogeneic Hematopoietic Stem Cell transplantation.

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

Thrombotic Microangiopathy with Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant from a Matched Unrelated Donor

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy.

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Non-Ablative or Reduced Intensity Conditioning Regimens with Volunteer Unrelated Donor Progenitor Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only